14 October, 2025“Spain has a great opportunity in the biopharmaceutical sector, but it must review its policies to maintain and increase its potential and attract investment in R&D and in industrial and digital assets.”The president of Farmaindustria, Fina Lladós, calls for a regulatory framework that improves the country’s competitiveness in order to turn the current situation of global uncertainty […]